OXIDIEN PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Nov 2022)
What this means for you
This application is over — abandoned 14 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88429708
- Mark type
- Stylized text
- Filed
- 14 May 2019
- Published for opposition
- 13 Aug 2019
- Abandoned
- 14 Nov 2022
- Attorney of record
- Amber N. Davis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, substances and products for use in nephrology and urology, namely, for the treatment and prevention of kidney-related disease such as kidney stones, hyperoxaluria, hyperoxalemia, and chronic kidney disease
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
- Class 042 — Scientific and technological services: Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; scientific and technological services, namely, research and development of new products for others, scientific research in the field of pharmaceutics, scientific laboratory services; medical and pharmacological research services, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs; natural science services, namely, biological research, chemical analysis of industrial and clinical fluids; medical and scientific research; pharmaceutical research and development; and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs; product development of probes, reagents and bioassays for industrial and scientific purposes
Owner
- OXIDIEN PHARMACEUTICALS, LLC, LEXINGTON, MA, US
- OXIDIEN PHARMACEUTICALS, LLC, Lexington, MA, US
- Captozyme Inc., Gainesville, FL, US
- Captozyme Inc., Gainesville, FL, US
Prosecution history
- 14 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Apr 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Apr 2022 — SOU EXTENSION 5 GRANTED
- 04 Apr 2022 — SOU EXTENSION 5 FILED
- 11 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Sept 2021 — SOU EXTENSION 4 GRANTED
- 22 Sept 2021 — SOU EXTENSION 4 FILED
- 22 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 14 Jun 2021 — ASSIGNED TO EXAMINER
- 13 May 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 May 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED